Dr. Patrice Renee Akins is a pharmacist who is specialized in Pharmacotherapy in Springfield, Virginia. Patients can reach her at 6501 Loisdale Ct, 5th Floor, Springfield or contact her on 703-922-1543. Active license number of Dr. Patrice Renee Akins is 16602 for Pharmacotherapy in Maryland. Dr. Patrice Renee Akins is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Dr. Patrice Renee Akins speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Patrice Renee Akins are as mentioned below.
NPI Number:
1952439788
NPI Enumeration Date:
01 Mar, 2007
NPI Last Update On:
20 Aug, 2013
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Patrice Renee Akins are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
16602
Maryland
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
6501 Loisdale Ct, 5th Floor Springfield, Virginia
Zip:
22150-1826
Phone Number:
703-922-1543
Fax Number:
--
Patients can reach Dr. Patrice Renee Akins at 6501 Loisdale Ct, 5th Floor, Springfield, Virginia or can call on phone at 703-922-1543.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.